Coronary atherosclerotic heart disease
Conditions
Interventions
Guanxinning treatment:Guanxinning treatment
conventional drug treatment group:conventional drug treatment
Sponsors
The First Affiliated Hospital of Bengbu Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Meet the diagnostic criteria for coronary heart disease (CHD); 2.Possess good communication and comprehension abilities: those with an educational background of primary school or above, or those who can communicate effectively with the assistance of family members; 3.Meet the diagnostic criteria for anxiety and depression.
Exclusion criteria
Exclusion criteria: 1.Patients with life-threatening conditions due to complicated severe heart, lung, or renal impairment, including those with consciousness disturbance, coma, etc. 2.Patients with complicated cognitive or language dysfunction, etc. 3.Pregnant women and those with contraindications to this drug such as bleeding tendency; 4. Patients who need to discontinue the study due to unexpected circumstances during the project period; 5. Patients with poor compliance or who are unwilling to complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety ?Depression ?for quality of life assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| cardiovascular events; | — |
Countries
China
Contacts
Public ContactXuan Ling
The First Affiliated Hospital of Bengbu Medical University
Outcome results
None listed